and enhances metabolism
Oral semaglutide was superior to placebo, sitagliptin, and liraglutide and similar to empagliflozin, with losses up to 4.44 kg compared with 0.53.6 kg for active-comparator arms and 0.41.4 kg compared with placebo [35,36,37,38,39,40]
On average, individuals treated with retatrutide experienced a 17.5% reduction in body weight at 24 weeks and a 24.2% reduction after 48 weeks
A recent study showed that semaglutide weight loss is effective in many areas, especially the stomach, and can help patients lose belly fat
The American Diabetes Association and American College of Physicians emphasize that medication should complementnot replacefoundational lifestyle interventions including nutrition optimization, physical activity, and behavioral strategies